Global Manufacturing

7 manufacturing sites in Yantai, Nanjing, Beijing, Luzhou and Chengdu of China, among which microsphere injection workshop for producing Rykindo® passed the U.S. FDA Pre-approval inspection, EU GMP inspections. The manufacturing facility for Erzofri® passed the pre-approval inspection by the U.S. FDA. And the topical/oral preparation workshop passed Australian TGA GMP and EU GMP inspections

1 manufacturing site in Germany passed EU GMP, FDA cGMP, Japanese GMP and Brazilian ANVISA inspections

Global R&D

R&D centers in China, the U.S. and
Europe with a robust pipeline of
30+ drug candidates in China
and 10+ drug candidates overseas

A series of innovative antibody and biosimilar products are under development

Several new drugs are under clinical trails in the U.S., Europe and Japan

Global Market

Key products covering the central nervous system,
oncology, cardiovascular and other therapeutic areas

30+ products covering 80+ countries and regions
worldwide including large pharmaceutical markets -
China, the U.S., Europe and Japan, as well as fast
growing emerging markets

Global R&D

R&D centers in China, the U.S. and Europe with a robust pipeline of 30+ drug candidates in China and 10+ drug candidates in other international markets

A series of innovative antibody and biosimilar products are under development

Several new drugs are under cinical trails in the U.S., Europe and Japan

Global Manufacturing

7 manufacturing sites in Yantai, Nanjing, Beijing, Luzhou and Chengdu of China, among which microsphere injection workshop for producing Rykindo® passed the U.S. FDA Pre-approval inspection, EU GMP inspections. The manufacturing facility for Erzofri® passed the pre-approval inspection by the U.S. FDA. And the topical/oral preparation workshop passed Australian TGA GMP and EU GMP inspections

1 manufacturing site in Germany passed EU GMP, FDA cGMP, Japanese GMP and Brazilian ANVISA inspections

Global Market

Key products covering the central nervous system, oncology, cardiovascular and other therapeutic areas

 

30+ products covering 80+ countries and regions around the world, including large pharmaceutical markets - China, the U.S., Europe and Japan, as well as fast growing emerging markets

 

Culture

Mission

Advanced Technologies for
Better Quality of Life

Vision

To Be a Leading Global
Pharmaceutical Company

Business Philosophy

Customer Focus, Operational Excellence, Employee Development

Core Values

Integrity, Cooperation, Innovation, Excellence

History

1994-2010
+
  • 1994
    The establishment of Luye Pharma
  • 1998
    Established Intellectual Property Dept. and International Cooperation Dept. to pursue international development
  • 1999

    Established an R&D Center, systematically building drug research and development capabilities

    The new GMP standard plant started operations, employing an international quality management system

  • 2007
    Acquired Nanjing Kanghai, Nanjing Sike and Beijing WBL Peking University Biotech, strengthening the oncology and cardiovascular portfolios
  • 2010
    Established the Laboratory for Long-acting and Targeting Drug Delivery Systems, to mainly focus on the development of novel drug delivery technologies
2011-2016
+
  • 2011
    Acquired Sichuan Baoguang Pharmaceutical, strengthening its business in the endocrine and metabolism fields
  • 2013

    Topical/Oral Preparation Workshop passed EU GMP inspections

    Multiple new drugs in the CNS field were registered and undergoing clinical trials in the U.S., to drive the global R&D strategy

  • 2014
    Listed on the main board of the Hong Kong Stock Exchange, speeding up the global strategy
  • 2016

    Acquired the transdermal drug delivery system business of a Swiss pharmaceutical company Acino, expanding operations to major international markets including Europe and the U.S.

2017-2024
+
  • 2018

    Acquired AstraZeneca's Seroquel and Seroquel XR in 51 countries and regions, accelerating the creation of a global commercial network

  • 2019

    Collaborated with AstraZeneca to promote high-quality TCM product- Xuezhikang to China and global markets

    Licensed by PharmaMar to develop Lurbinectedin in China, enabling Chinese patients to benefit from this innovative therapy

  • 2020

    Acquired Boan, accelerating development in the field of biopharmaceuticals

    The once-daily Rivastigmine Transdermal Patch received market approval in China, to help improve safe treatment for patients with Alzheimer's disease

  • 2021
    Began to reap the benefits of R&D with the approval of Ruiketuo (risperidone microspheres for injection (II)) and Boyounuo (bevacizumab injection) in China, and Rivastigmine Twice Weekly Transdermal Patch in several European countries.
  • 2022

    Boan Biotech was listed on the Main Board of the Hong Kong Stock Exchange, accelerating its journey towards becoming a leading global biopharmaceutical company.

    Ruoxinlin (toludesvenlafaxine hydrochloride sustained-release tablets) and Boyoubei (denosumab injection 60mg) were approved for marketing in China.

  • 2023
    More investigational drugs were approved for marketing, including Rykindo (risperidone) for extended-release injectable suspension in the U.S., Baituowei (goserelin microspheres for injection) in China, and Lurbinectedin in China’s Hong Kong SAR and Macao SAR.
  • 2024
    Boluojia (denosumab injection 120mg), Meibirui (paliperidone palmitate injection), Jinyouping (rotigotine microspheres for injection), Mimeixin (oxycodone hydrochloride and naloxone hydrochloride sustained-release tablets) were approved for marketing in China; Erzofri  (paliperidone palmitate) extended-release injectable suspension  was approved for marketing in the U.S.

History

1994-2010
+
  • 1994The establishment of Luye Pharma
  • 1998Established Intellectual Property Dept. and International Cooperation Dept. to pursue international development
  • 1999Established an R&D Center, systematically building drug research and development capabilities
    The new GMP standard plant started operations, employing an international quality management system
  • 2007Acquired Nanjing Kanghai, Nanjing Sike and Beijing WBL Peking University Biotech, strengthening the oncology and cardiovascular portfolios
  • 2010Established the Laboratory for Long-acting and Targeting Drug Delivery Systems, to mainly focus on the development of novel drug delivery technologies
2011-2016
+
  • 2011Acquired Sichuan Baoguang Pharmaceutical, strengthening its business in the endocrine and metabolism fields
  • 2013

    Topical/Oral Preparation Workshop passed EU GMP inspections

    Multiple new drugs in the CNS field were registered and undergoing clinical trials in the U.S., to drive the global R&D strategy

  • 2014Listed on the main board of the Hong Kong Stock Exchange, speeding up the global strategy
  • 2016

    Acquired the transdermal drug delivery system business of a Swiss pharmaceutical company Acino, expanding operations to major international markets including Europe and the U.S.

2017-2024
+
  • 2018

    Acquired AstraZeneca's Seroquel and Seroquel XR in 51 countries and regions, accelerating the creation of a global commercial network

  • 2019

    Collaborated with AstraZeneca to promote high-quality TCM product- Xuezhikang to China and global markets

    Licensed by PharmaMar to develop Lurbinectedin in China, enabling Chinese patients to benefit from this innovative therapy

  • 2020

    Acquired Boan, accelerating development in the field of biopharmaceuticals

    The once-daily Rivastigmine Transdermal Patch received market approval in China, to help improve safe treatment for patients with Alzheimer's disease

  • 2021Began to reap the benefits of R&D with the approval of Ruiketuo (risperidone microspheres for injection (II)) and Boyounuo (bevacizumab injection) in China, and Rivastigmine Twice Weekly Transdermal Patch in several European countries.
  • 2022

    Boan Biotech was listed on the Main Board of the Hong Kong Stock Exchange, accelerating its journey towards becoming a leading global biopharmaceutical company.

    Ruoxinlin (toludesvenlafaxine hydrochloride sustained-release tablets) and Boyoubei (denosumab injection 60mg) were approved for marketing in China.

  • 2023More investigational drugs were approved for marketing, including Rykindo (risperidone) for extended-release injectable suspension in the U.S., Baituowei (goserelin microspheres for injection) in China, and Lurbinectedin in China’s Hong Kong SAR and Macao SAR.
  • 2024Boluojia (denosumab injection 120mg), Meibirui (paliperidone palmitate injection), Jinyouping (rotigotine microspheres for injection), Mimeixin (oxycodone hydrochloride and naloxone hydrochloride sustained-release tablets) were approved for marketing in China; Erzofri  (paliperidone palmitate) extended-release injectable suspension  was approved for marketing in the U.S.

Responsibility

We are dedicated to becoming a leading global pharmaceutical company. We have both clear business goals and ambitious social objectives as part of the vision we want to realize. We are concerned about the environment, support education, encourage innovation, care about patients and serve the community. We aim to actively fulfill our corporate social responsibility and serve the community wholeheartedly while doing business.

Public Benefit Activities
Education Grants
Community Services
Environmental Protection

Patient Assistance Activities

Boyounuo Patient Assistance Program

In June 2021, Luye Pharma Group's subsidiary Boan Biotech and Beijing Health Alliance Charitable Foundation jointly launched the Boyounuo Patient Assistance Program, which is carried out across China. Its goal is to alleviate the financial burden of patients who are in need of assistance by providing them with drugs. Boan Biotech donates Boyounuo (Bevacizumab Injection) to Beijing Health Alliance Charitable Foundation, while the latter takes charge of the management and operation of the program and provides charitable drugs to applicants who qualify for the program.

Patient Assistance Activities

Lipusu Patient Assistance Program

In May 2018, the Lipusu Patient Assistance Program initiated by Luye Pharma and Beijing Kangmeng Charity Foundation, was launched in Xi'an, China. The program helps cancer patients by offering them the opportunity to receive timely, standardized and effective treatment, reducing patients’ financial burden, lower mortality rate and improve quality of life. The program has since benefited approximately 2000 patients with a total drug value of around RMB 30 million contributed by the company.

Patient Assistance Activities

Xuezhikang Primary Prevention Program

In August 2017, Luye Pharma officially launched the Xuezhikang Primary Prevention Program at the First Hospital of China Medical University and the Chaoyang Central Hospital, both located in Chaoyang, Liaoning Province. The program aims to strengthen the prevention and treatment of cardiovascular disease in poverty-stricken areas of Liaoning Province, so as to effectively control these diseases among low-income rural inhabitants and relieve disease-related poverty and return to poverty. The project team carries out disease screening among local villagers and provides medication to high-risk groups. In addition, the project team is also committed to improving disease awareness among local residents as well as chronic disease management capabilities among rural doctors.

Patient Assistance Activities

APL Patient Assistance Program

The launch ceremony for the Cancer Foundation of China’s Patient Assistance Program took place at Henan Cancer Hospital, one of the program’s adopted hospitals in 2012. Luye Pharma donated RMB 4.35 million worth of Yitaida (a cancer treatment drug) to the Cancer Foundation for the purpose of treating impoverished patients with APL (Acute Promyelocytic Leukemia).

Patient Assistance Activities

CFC (Cancer Foundation of China) Poverty-Stricken Cancer Patient Assistance Program

In April 2011, Nanjing Luye Pharmaceutical Co. Ltd donated RMB 500,000 worth of liposomal paclitaxel (brand name: Lipusu) to the Shanghai Thoracic Hospital, to provide free assistance to a number of impoverished cancer patients.

Patient Assistance Activities

Ethnic Minority Breast Cancer Screening Project

From June to August 2012, Nanjing Luye Pharmaceutical Co. Ltd. supported a breast cancer screening program run by the Cancer Foundation of China in the Inner Mongolia Autonomous Region, where breast cancer is highly prevalent and herdsmen live scattered without sufficient medical resources. As part of the project, more than 10,000 women of different ethnic minorities were screened free of charge by cancer specialists from across the country.

Donations

Supporting the Fight Against COVID-19

·Donation to medical staff in Wuhan city and other rural areas in China for COVID-19 pandemic prevention and control
·Continuous donation of supplies to social organizations, including Tiandixin (Lentinan for Injection), Maitongna (Sodium Aescinate for Injection) and other drugs
·Offices in New Jersey and Boston in the U.S. donated medical supplies to local communities and medical centers
·Initiated “We Care About Mental Health” campaign in APAC and Latin America to raise awareness for potential mental health issues caused by the pandemic

Donations

Xinjiang Assistance Program

In November 2017, Luye Pharma participated in the Xinjiang Assistance Program initiated by the Shandong Pharmaceutical Industry Association. Together with representatives of key enterprises from Shandong Province’s pharmaceutical industry, Luye Pharma donated RMB 1 million towards the provision of physical exercise facilities to medical staff from Shandong Province providing support in the Xinjiang Uyghur Autonomous Region.

Donations

Donation to Disaster-affected Children

In August 2010, Nanjing Luye Pharmaceutical Co., Ltd., a member of Luye Pharma Group, contributed RMB 100,000 towards children aid in Gansu Province's Zhouqu County, struck by devastating mudflows.

Donations

China Children's Charity Award

On May 31, 2009, Luye Pharma won the "China Children’s Charity Award" awarded by the All China Women's Federation (ACWF) and the China Children and Teenagers Fund (CCTF).

Donations

Wenchuan Disaster Relief

After an earthquake destroyed Wenchuan, Sichuan, in May 2008, the companies under the Luye Pharma Group made cumulative contributions of nearly RMB 3 million in cash and over RMB 1 million worth of disaster relief goods.

University Awards and Funding Projects

Peking University and Luye Pharma Biomedical Innovation Fund

In October 2010, China’s Peking University and Luye Pharma jointly signed an agreement to set up the “Peking University and Luye Pharma Biomedical Innovation Fund”. Under the agreement, Luye Pharma pledged to donate RMB 10 million to Peking University, aimed at supporting the university’s work in education and scientific research in the biomedical field. The donation amount of RMB 1 million was disbursed each year from 2011 to 2018 and will continue until 2020.

University Awards and Funding Projects

Peking University Medical School & Luye Scholarship and Grants

The scholarship and grants were established in 2015 by Luye Pharma Group and Peking University Medical School for a planned duration of ten years, with RMB 100,000 to be donated each year towards outstanding students in financial difficulty.

University Awards and Funding Projects

Luye Pharma Scholarship at School of Pharmacy, Yantai University

From 2010 to 2014, Luye Pharma established the “Luye Pharma Scholarship” at China’s Yantai University, contributing RMB 300,000 to support students with financial difficulties and reward students with outstanding academic performances. From 2015 to 2019, the company contributed an additional RMB 1 million to be distributed and awarded to students who were creative, innovative, entrepreneurial or socially active on top of their academic excellence.

University Awards and Funding Projects

Peking University Sunshine Fund • Love Scholarship & Peking University WPU Medical Education Award

In June 2006, Luye Pharma donated RMB 1 million to jointly set up the "Peking University Sunshine Fund • Love Scholarship" and "Peking University WPU Medical Education Award" with the Peking University Health Science Center. This program was completed in 2015.

University Awards and Funding Projects

Luye University Student Scholarship

Luye Pharma Nanjing Co. Ltd. founded the “Luye University Student Scholarship” in 2015, donating RMB 200,000 annually to support low income university freshmen who are committed to pursuing education.

School Donation and Funding Projects

Beijing WPU Hope Primary School in Sichuan Province

Beijing WBL Peking University Biotech Co. Ltd. reached out to donate funds to rebuild Tongling Primary School in Puxing Town, Sichuan, which was badly damaged during the 2008 Wenchuan earthquake. The reconstructed school was able to continue offering early childhood and preschool education as well as primary school programs. Every year, Beijing WBL Peking University Biotech volunteers will return to the school with stationery supplies as a contribution to the students.

School Donation and Funding Projects

Primary Schools in Sichuan Province

In May 2008, Luye Pharma, joined hands with the China Children and Teenagers Fund and contributed 1 million yuan towards the construction of two primary schools in Tumen Town, Mianzhu County, Sichuan Province. On June 18, Luye Pharma employees donated over 200,000 yuan worth of books and stationery. On May 31, 2010, employees of Luye Pharma revisited the earthquake-stricken area of Wenchuan, Tumen Town, Mianzhu County, Sichuan Province, and donated 50,000 yuan to the Tumen Central Primary School and Tumen Central Secondary School, respectively. The donated funds were used to purchase teaching equipment and set up the Luye Love Scholarship.

School Donation and Funding Projects

Primary School in Xuyi

In 2009, Luye Pharma Nanjing Co. Ltd. cooperated with Jiangsu Provincial Children’s Foundation and donated RMB 200,000 to construct a primary school in Xuyi. In 2010, the company donated another RMB 200,000 to the Foundation to improve the teaching conditions, and funded 100 orphans, offering them each a scholarship of RMB 1,000 annually.

School Donation and Funding Projects

Charity Program for Students in Jiangsu Province

Luye Pharma Nanjing Co. Ltd. kickstarted a campaign in 2009 to improve the learning environment of three schools in China’ s Northern Jiangsu Province and provide financial support to children in need. It also initiated a “Music Seed” event to support children who have difficulties learning or face challenges in their family life.

School Donation and Funding Projects

Luye Love Aid Program in Laishan, Yantai City

Since 2004, the company has donated RMB 100,000 to the Laishan Education Bureau of Yantai City, Shandong Province to help impoverished students in primary and secondary schools in the area.

School Donation and Funding Projects

Equipment Assistance

In September 2013, Luye Pharma Group donated 12 sets of pharmaceutical equipment worth more than RMB 600,000 to the Shandong Drug and Food Vocational College. The equipment is to be used in practical learning and to train students in equipment assembly and disassembly, with the multiple aim to help enrich student-teacher interactions, improve students' practical abilities, and help students better understand the drug production process within an enterprise.

School Donation and Funding Projects

Financial Aid Program in West China School of Medicine, Sichuan University

Luye Pharma and the West China School of Medicine, Sichuan University have jointly set up the Financial Aid program. The company donates RMB 100,000 every year to help university students in financial difficulty complete their studies. It has so far contributed RMB 700,000 in total.

Community Services

Luye Laishan Half Marathon

To help promote physical activity, improve the physical fitness of the population in general, and spread health awareness, Luye Pharma has been sponsoring the Laishan Half Marathon since 2013. The Luye Half Marathon has today become a well-known local sports brand, attracting tens of thousands of athletes every year.

Community Services

Hand in Hand Care Action Program

In April 2016, volunteers from Shandong Luye Pharmaceutical Co., Ltd. actively participated in the Hand in Hand Care Action program, aimed at helping impoverished children, and purchased gifts for students from financially challenged families at Laishan Central Primary School and Chenjia Primary School.

Community Services

Sunset Red – Elderly Care Public Welfare Activities

In April 2018, Sichuan Luye organized a visit by employees to the Yutang Town Home for the Elderly, where they extended their sympathy and solicitude to the elderly residents through specially designed activities.

Community Services

Luye Evergreen College Activities in Honor of Senior Citizens

On September 28, 2016, Luye Evergreen College students went to the Luzhou Zhongyi Gold Nursing Home to bring needed medical and health supplies to the elderly living there. Medical experts were invited to discuss health topics and a self-compiled and self-acted presentation was also given to the elderly.

EHS Responsibility

Environmental Policy, Objectives and Commitments

EHS policy: Focus on environment, health and safety to ensure sustainable development.

 

EHS objectives: Ensuring the integrated management system of environmental and occupational health and safety running in a normal way and improving it continuously.

 

EHS commitments: Maintain the management system, take effective measures for continuous improvement, and correct and prevent any deviation from the environmental and occupational health and safety policy, and environmental and occupational health and safety objectives.

 

To ensure that all the employees strictly follow the company's environmental and occupational health and safety policy, objectives and commitments, with first-class management, quality products and satisfactory service to continuously provide high-tech products to serve the market.

Patient Assistance Activities
Boyounuo Patient Assistance Program
In June 2021, Luye Pharma Group's subsidiary Boan Biotech and Beijing Health Alliance Charitable Foundation jointly launched the Boyounuo Patient Assistance Program, which is carried out across China. Its goal is to alleviate the financial burden of patients who are in need of assistance by providing them with drugs. Boan Biotech donates Boyounuo (Bevacizumab Injection) to Beijing Health Alliance Charitable Foundation, while the latter takes charge of the management and operation of the program and provides charitable drugs to applicants who qualify for the program.
Patient Assistance Activities
Lipusu Patient Assistance Program
In May 2018, the Lipusu Patient Assistance Program initiated by Luye Pharma and Beijing Kangmeng Charity Foundation, was launched in Xi'an, China. The program helps cancer patients by offering them the opportunity to receive timely, standardized and effective treatment, reducing patients’ financial burden, lower mortality rate and improve quality of life. The program has since benefited approximately 2000 patients with a total drug value of around RMB 30 million contributed by the company.
Patient Assistance Activities
Xuezhikang Primary Prevention Program
In August 2017, Luye Pharma officially launched the Xuezhikang Primary Prevention Program at the First Hospital of China Medical University and the Chaoyang Central Hospital, both located in Chaoyang, Liaoning Province. The program aims to strengthen the prevention and treatment of cardiovascular disease in poverty-stricken areas of Liaoning Province, so as to effectively control these diseases among low-income rural inhabitants and relieve disease-related poverty and return to poverty. The project team carries out disease screening among local villagers and provides medication to high-risk groups. In addition, the project team is also committed to improving disease awareness among local residents as well as chronic disease management capabilities among rural doctors.
Patient Assistance Activities
APL Patient Assistance Program
The launch ceremony for the Cancer Foundation of China’s Patient Assistance Program took place at Henan Cancer Hospital, one of the program’s adopted hospitals in 2012. Luye Pharma donated RMB 4.35 million worth of Yitaida (a cancer treatment drug) to the Cancer Foundation for the purpose of treating impoverished patients with APL (Acute Promyelocytic Leukemia).
Patient Assistance Activities
CFC (Cancer Foundation of China) Poverty-Stricken Cancer Patient Assistance Program
In April 2011, Nanjing Luye Pharmaceutical Co. Ltd donated RMB 500,000 worth of liposomal paclitaxel (brand name: Lipusu) to the Shanghai Thoracic Hospital, to provide free assistance to a number of impoverished cancer patients.
Patient Assistance Activities
Ethnic Minority Breast Cancer Screening Project
From June to August 2012, Nanjing Luye Pharmaceutical Co. Ltd. supported a breast cancer screening program run by the Cancer Foundation of China in the Inner Mongolia Autonomous Region, where breast cancer is highly prevalent and herdsmen live scattered without sufficient medical resources. As part of the project, more than 10,000 women of different ethnic minorities were screened free of charge by cancer specialists from across the country.
Donations
Supporting the Fight Against COVID-19
·Donation to medical staff in Wuhan city and other rural areas in China for COVID-19 pandemic prevention and control
·Continuous donation of supplies to social organizations, including Tiandixin (Lentinan for Injection), Maitongna (Sodium Aescinate for Injection) and other drugs
·Offices in New Jersey and Boston in the U.S. donated medical supplies to local communities and medical centers
·Initiated “We Care About Mental Health” campaign in APAC and Latin America to raise awareness for potential mental health issues caused by the pandemic
Donations
Xinjiang Assistance Program
In November 2017, Luye Pharma participated in the Xinjiang Assistance Program initiated by the Shandong Pharmaceutical Industry Association. Together with representatives of key enterprises from Shandong Province’s pharmaceutical industry, Luye Pharma donated RMB 1 million towards the provision of physical exercise facilities to medical staff from Shandong Province providing support in the Xinjiang Uyghur Autonomous Region.
Donations
Donation to Disaster-affected Children
In August 2010, Nanjing Luye Pharmaceutical Co., Ltd., a member of Luye Pharma Group, contributed RMB 100,000 towards children aid in Gansu Province's Zhouqu County, struck by devastating mudflows.
Donations
China Children's Charity Award
On May 31, 2009, Luye Pharma won the "China Children’s Charity Award" awarded by the All China Women's Federation (ACWF) and the China Children and Teenagers Fund (CCTF).
Donations
Wenchuan Disaster Relief
After an earthquake destroyed Wenchuan, Sichuan, in May 2008, the companies under the Luye Pharma Group made cumulative contributions of nearly RMB 3 million in cash and over RMB 1 million worth of disaster relief goods.
University Awards and Funding Projects
Peking University and Luye Pharma Biomedical Innovation Fund
In October 2010, China’s Peking University and Luye Pharma jointly signed an agreement to set up the “Peking University and Luye Pharma Biomedical Innovation Fund”. Under the agreement, Luye Pharma pledged to donate RMB 10 million to Peking University, aimed at supporting the university’s work in education and scientific research in the biomedical field. The donation amount of RMB 1 million was disbursed each year from 2011 to 2018 and will continue until 2020.
University Awards and Funding Projects
Peking University Medical School & Luye Scholarship and Grants
The scholarship and grants were established in 2015 by Luye Pharma Group and Peking University Medical School for a planned duration of ten years, with RMB 100,000 to be donated each year towards outstanding students in financial difficulty.
University Awards and Funding Projects
Luye Pharma Scholarship at School of Pharmacy, Yantai University
From 2010 to 2014, Luye Pharma established the “Luye Pharma Scholarship” at China’s Yantai University, contributing RMB 300,000 to support students with financial difficulties and reward students with outstanding academic performances. From 2015 to 2019, the company contributed an additional RMB 1 million to be distributed and awarded to students who were creative, innovative, entrepreneurial or socially active on top of their academic excellence.
University Awards and Funding Projects
Peking University Sunshine Fund • Love Scholarship & Peking University WPU Medical Education Award
In June 2006, Luye Pharma donated RMB 1 million to jointly set up the "Peking University Sunshine Fund • Love Scholarship" and "Peking University WPU Medical Education Award" with the Peking University Health Science Center. This program was completed in 2015.
University Awards and Funding Projects
Luye University Student Scholarship
Luye Pharma Nanjing Co. Ltd. founded the “Luye University Student Scholarship” in 2015, donating RMB 200,000 annually to support low income university freshmen who are committed to pursuing education.
School Donation and Funding Projects
Beijing WPU Hope Primary School in Sichuan Province
Beijing WBL Peking University Biotech Co. Ltd. reached out to donate funds to rebuild Tongling Primary School in Puxing Town, Sichuan, which was badly damaged during the 2008 Wenchuan earthquake. The reconstructed school was able to continue offering early childhood and preschool education as well as primary school programs. Every year, Beijing WBL Peking University Biotech volunteers will return to the school with stationery supplies as a contribution to the students.
School Donation and Funding Projects
Primary Schools in Sichuan Province
In May 2008, Luye Pharma, joined hands with the China Children and Teenagers Fund and contributed 1 million yuan towards the construction of two primary schools in Tumen Town, Mianzhu County, Sichuan Province. On June 18, Luye Pharma employees donated over 200,000 yuan worth of books and stationery. On May 31, 2010, employees of Luye Pharma revisited the earthquake-stricken area of Wenchuan, Tumen Town, Mianzhu County, Sichuan Province, and donated 50,000 yuan to the Tumen Central Primary School and Tumen Central Secondary School, respectively. The donated funds were used to purchase teaching equipment and set up the Luye Love Scholarship.
School Donation and Funding Projects
Primary School in Xuyi
In 2009, Luye Pharma Nanjing Co. Ltd. cooperated with Jiangsu Provincial Children’s Foundation and donated RMB 200,000 to construct a primary school in Xuyi. In 2010, the company donated another RMB 200,000 to the Foundation to improve the teaching conditions, and funded 100 orphans, offering them each a scholarship of RMB 1,000 annually.
School Donation and Funding Projects
Charity Program for Students in Jiangsu Province
Luye Pharma Nanjing Co. Ltd. kickstarted a campaign in 2009 to improve the learning environment of three schools in China’ s Northern Jiangsu Province and provide financial support to children in need. It also initiated a “Music Seed” event to support children who have difficulties learning or face challenges in their family life.
School Donation and Funding Projects
Luye Love Aid Program in Laishan, Yantai City
Since 2004, the company has donated RMB 100,000 to the Laishan Education Bureau of Yantai City, Shandong Province to help impoverished students in primary and secondary schools in the area.
School Donation and Funding Projects
Equipment Assistance
In September 2013, Luye Pharma Group donated 12 sets of pharmaceutical equipment worth more than RMB 600,000 to the Shandong Drug and Food Vocational College. The equipment is to be used in practical learning and to train students in equipment assembly and disassembly, with the multiple aim to help enrich student-teacher interactions, improve students' practical abilities, and help students better understand the drug production process within an enterprise.
School Donation and Funding Projects
Financial Aid Program in West China School of Medicine, Sichuan University
Luye Pharma and the West China School of Medicine, Sichuan University have jointly set up the Financial Aid program. The company donates RMB 100,000 every year to help university students in financial difficulty complete their studies. It has so far contributed RMB 700,000 in total.
Community Services
Luye Laishan Half Marathon
To help promote physical activity, improve the physical fitness of the population in general, and spread health awareness, Luye Pharma has been sponsoring the Laishan Half Marathon since 2013. The Luye Half Marathon has today become a well-known local sports brand, attracting tens of thousands of athletes every year.
Community Services
Hand in Hand Care Action Program
In April 2016, volunteers from Shandong Luye Pharmaceutical Co., Ltd. actively participated in the Hand in Hand Care Action program, aimed at helping impoverished children, and purchased gifts for students from financially challenged families at Laishan Central Primary School and Chenjia Primary School.
Community Services
Sunset Red – Elderly Care Public Welfare Activities
In April 2018, Sichuan Luye organized a visit by employees to the Yutang Town Home for the Elderly, where they extended their sympathy and solicitude to the elderly residents through specially designed activities.
Community Services
Luye Evergreen College Activities in Honor of Senior Citizens
On September 28, 2016, Luye Evergreen College students went to the Luzhou Zhongyi Gold Nursing Home to bring needed medical and health supplies to the elderly living there. Medical experts were invited to discuss health topics and a self-compiled and self-acted presentation was also given to the elderly.
EHS Responsibility

Environmental Policy, Objectives and Commitments

EHS policy: Focus on environment, health and safety to ensure sustainable development.

EHS objectives: Ensuring the integrated management system of environmental and occupational health and safety running in a normal way and improving it continuously.

EHS commitments: Maintain the management system, take effective measures for continuous improvement, and correct and prevent any deviation from the environmental and occupational health and safety policy, and environmental and occupational health and safety objectives.

To ensure that all the employees strictly follow the company's environmental and occupational health and safety policy, objectives and commitments, with first-class management, quality products and satisfactory service to continuously provide high-tech products to serve the market.